(Q44209447)

30 November 2017

title

Tackling multiple sclerosis (English)

1 reference

30 November 2017

Hartmut Wekerle

1

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

420

1 reference

30 November 2017

issue

6911

1 reference

30 November 2017

page(s)

39-40

1 reference

https://scigraph.springernature.com/pub.10.1038/420039a

30 November 2017

exact match

0 references

cites work

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

1 reference

Current perspectives on statins

21 January 2018

1 reference

Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses

21 January 2018

1 reference

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

21 January 2018

1 reference

Antigen decoding by T lymphocytes: from synapses to fate determination

21 January 2018

1 reference

Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives

21 January 2018

1 reference

Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis

21 January 2018

1 reference

Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin

21 January 2018

1 reference

Statins as a newly recognized type of immunomodulator

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1038/420039A

1 reference

Dimensions Publication ID

30 November 2017

1033337033

0 references

1 reference